drug
as of 2026-07-01Horyzons USA
at a glance
DEVICE
Pre-approval / investigational in the US
Developed by University of North Carolina, Chapel Hill
2 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
DEVICE
Indications
Trials
2
Horyzons: Implementation and Integration in Clinical Practice
NCT06002958—Terminated
Horyzons: Implementation in Clinical Practice
NCT04673851—Completed
KOLs & investigators
3
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
trial
indication
indication
indication
indication
KOL
Diana O. Perkins, MD, MPH
personKOL score 5
David L. Penn, PhD
personKOL score 5
Felice Reddy, PhD
personKOL score —